Paper8970972
Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
Grigera PR and 4 others. J Virol, 1996. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus. Papers, record 8970972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8970972
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Viral | Major topic |
| Aphthovirus | Major topic |
| Capsid | Major topic |
| Membrane Glycoproteins | Major topic |
| Vesiculovirus | Major topic |
| Viral Envelope Proteins | Major topic |
| Animals | |
| Antibodies, Viral | |
| Baculoviridae | |
| Capsid Proteins | |
| Cell Line | |
| Chlorocebus aethiops | |
| Cricetinae | |
| Foot-and-Mouth Disease | |
| Genetic Vectors | |
| Immunogenetics | |
| Neutralization Tests | |
| Precipitin Tests | |
| Recombinant Fusion Proteins | |
| Spodoptera |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R37 AI 11112 | NIAID NIH HHS | United States | R37AI011112 | PubMed and NIH |
Source NIH RePORTER
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,118,869 | The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. | J Virol | 1972 | https://conductscience.org/library/papers/4118869 | PubMed |
| 2 | 2,471,352 | Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector. | Virology | 1989 | https://conductscience.org/library/papers/2471352 | PubMed |
| 3 | 6,176,678 | Location and characterization of the antigenic portion of the FMDV immunizing protein. | J Gen Virol | 1982 | https://conductscience.org/library/papers/6176678 | PubMed |
| 4 | 2,981,435 | Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. | Science | 1985 | https://conductscience.org/library/papers/2981435 | PubMed |
| 5 | 3,008,333 | Protection of cattle against foot-and-mouth disease by a synthetic peptide. | Science | 1986 | https://conductscience.org/library/papers/3008333 | PubMed |
| 6 | 2,543,752 | The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). | J Gen Virol | 1989 | https://conductscience.org/library/papers/2543752 | PubMed |
| 7 | 2,155,177 | Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. | Immunology | 1990 | https://conductscience.org/library/papers/2155177 | PubMed |
| 8 | 1,690,261 | A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. | J Gen Virol | 1990 | https://conductscience.org/library/papers/1690261 | PubMed |
| 9 | 2,157,712 | Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2157712 | PubMed |
| 10 | 2,163,575 | Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. | Vaccine | 1990 | https://conductscience.org/library/papers/2163575 | PubMed |
| 11 | 2,168,107 | The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. | Virus Genes | 1990 | https://conductscience.org/library/papers/2168107 | PubMed |
| 12 | 1,369,994 | Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties. | Biotechnology (N Y) | 1990 | https://conductscience.org/library/papers/1369994 | PubMed |
| 13 | 2,234,068 | Product review. New mammalian expression vectors. | Nature | 1990 | https://conductscience.org/library/papers/2234068 | PubMed |
| 14 | 1,701,943 | Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype). | Virology | 1991 | https://conductscience.org/library/papers/1701943 | PubMed |
| 15 | 1,847,695 | High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. | Immunology | 1991 | https://conductscience.org/library/papers/1847695 | PubMed |
| 16 | 1,709,696 | Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. | J Virol | 1991 | https://conductscience.org/library/papers/1709696 | PubMed |
| 17 | 1,653,494 | Two mechanisms of antigenic diversification of foot-and-mouth disease virus. | Virology | 1991 | https://conductscience.org/library/papers/1653494 | PubMed |
| 18 | 1,658,362 | Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. | J Virol | 1991 | https://conductscience.org/library/papers/1658362 | PubMed |
| 19 | 1,312,129 | Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. | J Gen Virol | 1992 | https://conductscience.org/library/papers/1312129 | PubMed |
| 20 | 1,312,607 | Protective immune response against foot-and-mouth disease. | J Virol | 1992 | https://conductscience.org/library/papers/1312607 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16,186,807 | Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia. | Oncogene | 2006 | https://conductscience.org/library/papers/16186807 | PubMed |
| 15,668,698 | Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination. | Gene Ther | 2005 | https://conductscience.org/library/papers/15668698 | PubMed |
| 12,819,084 | Development of DNA vaccines against hemolytic-uremic syndrome in a murine model. | Infect Immun | 2003 | https://conductscience.org/library/papers/12819084 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8970972
GET https://conductscience.org/api/papers/v1/8970972/references?page=2